Glut1 Deficiency Summit

Poster Session

divider

We are pleased to be hosting a poster session in conjunction with the Summit to highlight recent research and discoveries relevant to Glut1 Deficiency as well as patient and family experiences. We are excited about the opportunity to expand and share knowledge and promote scientific collaboration among those interested in and dedicated to helping our community.

We invite participation from researchers, students, clinicians, dietitians, therapists, other healthcare professionals, industry, and patients/family members.

Copy of Dallas logo card-2
Subject Areas:
  • subject areas may include scientific research, clinical case studies, or patient/family experiences
  • please see our Research Compass for particular areas of interest 
  • original posters as well as those presented recently at other meetings are welcomed, just please note any previous presentations in the application
Poster Session Details:
  • The poster session and reception will take place in person on Wednesday evening, June 26th at 6:30 PM after the completion of the day's presentations
  • Poster setup should take place before 5:00 PM on Wednesday, June 26th
  • All posters accepted will be available for viewing throughout the remainder of the Summit
  • Presenting authors of accepted posters will receive free conference registration
  • Poster prizes will be awarded
  • Poster abstracts may be submitted through May 1, 2024.
  • Decisions and notifications will be made within 5 days of submission.
  • Please find the application submission form below.
Additional Information:
  • Limit the abstract title to 10 words or less.
  • Limit the abstract body to 500 words or less, including acknowledgements.
  • Provide 3-5 key words.
  • Use standard abbreviations when possible. Nonstandard abbreviations/acronyms should be spelled out.
  • List all contributing authors to the work. The presenting author should be listed first.
  • The presenting author should be a registrant of the conference (free registration code shared on poster acceptance).
  • Authors should disclose their sources of support (commercial, public or private grants).
  • Work presented must conform to NIH policies on using animal and human subjects in neuroscience research, ethics policies, and where applicable to the Declaration of Helsinki.
  • Work submitted for presentation shouldn't have been previously published in an archival scientific publication. However, recently presented posters are acceptable provided the other meetings and dates are included in the application.
  • The scientific abstract should state the study's objective, briefly describe methods used, summarize the results obtained, and state the conclusions.
  • The clinical case study abstract should include learning objectives and a brief summary of the patient presentation, workup, treatment, and main teaching points the case illustrates.
  • The patient/family abstract could follow the clinical case study format above or contain unique presentation details to enhance understanding of the patient experience (examples:  A Day in My Life, My Biggest Challenges, My Greatest Accomplishments, My Hope for the Future, Glut1 Deficiency's Impact on Our Family, etc.)
  • Abstracts should be submitted in English.
  • Authors will be notified of acceptance or rejection within 5 days of submission along with further instructions.
  • Posters should be sized to fit a 36" x 48" display board (horizontal or vertical orientation) and also will be shared in digital form PDF form on our virtual conference platform.
  • Applications may be submitted through May 1, 2024.
sun

Poster Abstract Submission

"*" indicates required fields

presenting author's name:*
affiliation or institution address*